Rebecca Lin, Eight Roads Ventures

Rebecca Lin, a Senior Partner at Eight Roads Ventures China, focuses primarily on healthcare investments across. See sector focus and contact routes.

About Rebecca Lin

Rebecca Lin, a Senior Partner at Eight Roads Ventures China, focuses primarily on healthcare investments across therapeutics, medtech, and digital solutions, having joined the firm in 2007 to invest in this sparse market. Her notable portfolio includes TCT Medical (her first healthcare deal), AutoNavi (NASDAQ: AMAP), China Cord Blood (NYSE: CO), and Eyebright Medical Technology, which successfully IPO'd on the Shanghai STAR Market. Lin distinguishes her approach by acting as a venture co-founder, actively building companies like Citrine Medicine (rare diseases) and Pediatrix Therapeutics (pediatrics) alongside partners to address specific clinical unmet needs in China.

Rebecca Lin at a glance

Role
Partner
Organization
Eight Roads Ventures
Location
Jingan, Shanghai, China
Investor type
Venture Capital
Focus areas
Healthcare

Frequently asked about Rebecca Lin

What does Rebecca Lin invest in?
Rebecca Lin at Eight Roads Ventures (Jingan, Shanghai, China) — sector focus: Healthcare.
How do I contact Rebecca Lin?
Rebecca Lin's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Rebecca Lin based?
Rebecca Lin is based in Jingan, Shanghai, China.

Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Jingan.

Investors similar to Rebecca Lin (20)

Browse related investor lists (1)

Compare Rebecca Lin (8)

Investors like Rebecca Lin · Full investor directory · Investor access · Company funding database